Valuation: LifeTech Scientific Corporation

Market Cap 5.22B 779M 692M 647M 587M 1.11B 75.1B 1.12B 7.77B 3.02B 38.31B 2.92B 2.86B 123B P/E 2024
25.7x
P/E 2025 42.5x
Enterprise Value 4.08B 609M 540M 506M 458M 866M 58.68B 872M 6.07B 2.36B 29.94B 2.28B 2.24B 96.24B EV / Sales 2024
3.74x
EV / Sales 2025 3.91x
Free-Float
77.55%
Yield 2024 *
-
Yield 2025 -
1 week-3.52%
Current month-5.52%
1 month-1.44%
3 months-9.27%
6 months-26.74%
Current year-13.84%
1 week 0.14
Extreme 0.137
0.15
1 month 0.14
Extreme 0.135
0.15
3 years 0.12
Extreme 0.12
0.3
Manager TitleAgeSince
Chief Executive Officer 56 2015-03-01
Director of Finance/CFO 55 2010-08-31
Corporate Officer/Principal - 2026-05-21
Director TitleAgeSince
Chairman 56 2006-08-16
Director/Board Member 63 2014-03-31
Director/Board Member 68 2014-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%-3.52%-34.13%-50.00% 767M
-2.98%-3.39%+20.71%+31.70% 250B
-2.53%-4.64%+1.84%-0.75% 156B
-0.42%-1.80%-9.99%+36.89% 144B
-0.50%-3.85%-56.37%-19.05% 61.45B
-0.86%-1.82%+12.96%+17.34% 50.28B
+1.66%-1.55%-20.09%-20.26% 46.73B
-1.00%-3.26%+19.57%+53.05% 48.29B
+0.02%+1.77%-5.42%+35.26% 45.89B
-0.84%-1.54%+33.21%+63.21% 43.24B
Average -0.57%-2.32%-3.77%+14.74% 93.91B
Weighted average by Cap. -1.23%-2.77%+2.82%+22.16%

Financials

2024 2025
Net sales 1.3B 194M 173M 162M 146M 277M 18.74B 279M 1.94B 755M 9.56B 730M 714M 30.74B 1.37B 204M 181M 170M 154M 291M 19.69B 293M 2.04B 793M 10.05B 767M 750M 32.3B
Net income 222M 33.17M 29.44M 27.55M 24.97M 47.17M 3.2B 47.51M 331M 129M 1.63B 125M 122M 5.24B 148M 22.05M 19.57M 18.32M 16.6M 31.35M 2.13B 31.58M 220M 85.56M 1.08B 82.76M 80.99M 3.49B
Net Debt -1.18B -176M -156M -146M -132M -250M -16.92B -251M -1.75B -681M -8.63B -659M -645M -27.75B -1.14B -170M -151M -142M -128M -242M -16.42B -244M -1.7B -661M -8.38B -639M -626M -26.93B
Projected Income Statement - Annual - LifeTech Scientific Corporation
Logo LifeTech Scientific Corporation
LifeTech Scientific Corp is an investment holding company primarily engaged in the development, manufacture and trading of interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company mainly operates its business through three segments. The Structural Heart Diseases Business segment is engaged in trading, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in trading, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment is engaged in trading, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The Company conducts its business in the domestic and overseas markets.
Employees
-
Date Price Change
26-10-06 €0.1390 +1.46%
26-10-05 €0.1370 0.00%
26-10-02 €0.1370 -6.16%
26-10-01 €0.1460 +0.69%
26-09-30 €0.1450 +0.69%
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Ratings Surperformance© - LifeTech Scientific Corporation

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - LifeTech Scientific Corporation